Logo image of ALVAP.PA

KUMULUS VAPE (ALVAP.PA) Stock Fundamental Analysis

EPA:ALVAP - Euronext Paris - Matif - FR0013419876 - Common Stock - Currency: EUR

5.34  +0.28 (+5.53%)

Fundamental Rating

6

Taking everything into account, ALVAP scores 6 out of 10 in our fundamental rating. ALVAP was compared to 50 industry peers in the Specialty Retail industry. ALVAP has an average financial health and profitability rating. ALVAP has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year ALVAP was profitable.
Each year in the past 5 years ALVAP has been profitable.
ALVAP had negative operating cash flow in 4 of the past 5 years.
ALVAP.PA Yearly Net Income VS EBIT VS OCF VS FCFALVAP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 2M -2M 4M 6M

1.2 Ratios

The Return On Assets of ALVAP (11.93%) is better than 92.00% of its industry peers.
With an excellent Return On Equity value of 19.68%, ALVAP belongs to the best of the industry, outperforming 88.00% of the companies in the same industry.
The Return On Invested Capital of ALVAP (17.26%) is better than 90.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ALVAP is significantly above the industry average of 9.50%.
The last Return On Invested Capital (17.26%) for ALVAP is above the 3 year average (14.54%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 11.93%
ROE 19.68%
ROIC 17.26%
ROA(3y)10.22%
ROA(5y)8.85%
ROE(3y)15.46%
ROE(5y)14.08%
ROIC(3y)14.54%
ROIC(5y)14.31%
ALVAP.PA Yearly ROA, ROE, ROICALVAP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

ALVAP has a Profit Margin of 3.16%. This is in the better half of the industry: ALVAP outperforms 72.00% of its industry peers.
ALVAP's Profit Margin has declined in the last couple of years.
With a decent Operating Margin value of 4.84%, ALVAP is doing good in the industry, outperforming 68.00% of the companies in the same industry.
ALVAP's Operating Margin has declined in the last couple of years.
ALVAP has a worse Gross Margin (22.53%) than 72.00% of its industry peers.
In the last couple of years the Gross Margin of ALVAP has grown nicely.
Industry RankSector Rank
OM 4.84%
PM (TTM) 3.16%
GM 22.53%
OM growth 3Y-6.99%
OM growth 5YN/A
PM growth 3Y-6.57%
PM growth 5YN/A
GM growth 3Y3.52%
GM growth 5YN/A
ALVAP.PA Yearly Profit, Operating, Gross MarginsALVAP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 5 10 15 20

More info and screens

6

2. Health

2.1 Basic Checks

ALVAP has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for ALVAP has been increased compared to 1 year ago.
ALVAP has a worse debt/assets ratio than last year.
ALVAP.PA Yearly Shares OutstandingALVAP.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 1M 2M 3M
ALVAP.PA Yearly Total Debt VS Total AssetsALVAP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

2.2 Solvency

An Altman-Z score of 6.44 indicates that ALVAP is not in any danger for bankruptcy at the moment.
ALVAP has a Altman-Z score of 6.44. This is amongst the best in the industry. ALVAP outperforms 96.00% of its industry peers.
ALVAP has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.26, ALVAP is in the better half of the industry, outperforming 78.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z 6.44
ROIC/WACC2.36
WACC7.3%
ALVAP.PA Yearly LT Debt VS Equity VS FCFALVAP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 5M 10M

2.3 Liquidity

A Current Ratio of 3.49 indicates that ALVAP has no problem at all paying its short term obligations.
ALVAP has a Current ratio of 3.49. This is amongst the best in the industry. ALVAP outperforms 96.00% of its industry peers.
ALVAP has a Quick Ratio of 1.89. This is a normal value and indicates that ALVAP is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.89, ALVAP belongs to the top of the industry, outperforming 90.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.49
Quick Ratio 1.89
ALVAP.PA Yearly Current Assets VS Current LiabilitesALVAP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 5M 10M 15M 20M

More info and screens

6

3. Growth

3.1 Past

ALVAP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.14%, which is quite good.
ALVAP shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 28.22% yearly.
Looking at the last year, ALVAP shows a very strong growth in Revenue. The Revenue has grown by 53.66%.
ALVAP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 40.66% yearly.
EPS 1Y (TTM)11.14%
EPS 3Y28.22%
EPS 5YN/A
EPS Q2Q%-18.21%
Revenue 1Y (TTM)53.66%
Revenue growth 3Y40.66%
Revenue growth 5YN/A
Sales Q2Q%2.01%

3.2 Future

Based on estimates for the next years, ALVAP will show a small growth in Earnings Per Share. The EPS will grow by 4.97% on average per year.
Based on estimates for the next years, ALVAP will show a small growth in Revenue. The Revenue will grow by 2.38% on average per year.
EPS Next Y-2.41%
EPS Next 2Y1.2%
EPS Next 3Y4.97%
EPS Next 5YN/A
Revenue Next Year1.16%
Revenue Next 2Y1.36%
Revenue Next 3Y2.38%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALVAP.PA Yearly Revenue VS EstimatesALVAP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
ALVAP.PA Yearly EPS VS EstimatesALVAP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 5.56, which indicates a rather cheap valuation of ALVAP.
Based on the Price/Earnings ratio, ALVAP is valued cheaper than 96.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.60, ALVAP is valued rather cheaply.
With a Price/Forward Earnings ratio of 6.10, the valuation of ALVAP can be described as very cheap.
94.00% of the companies in the same industry are more expensive than ALVAP, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.43. ALVAP is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 5.56
Fwd PE 6.1
ALVAP.PA Price Earnings VS Forward Price EarningsALVAP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

92.00% of the companies in the same industry are more expensive than ALVAP, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.87
ALVAP.PA Per share dataALVAP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The decent profitability rating of ALVAP may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.2%
EPS Next 3Y4.97%

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.01%, ALVAP has a reasonable but not impressive dividend return.
ALVAP's Dividend Yield is rather good when compared to the industry average which is at 4.81. ALVAP pays more dividend than 82.00% of the companies in the same industry.
ALVAP's Dividend Yield is a higher than the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 3.01%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALVAP.PA Yearly Dividends per shareALVAP.PA Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 0.05 0.1

5.3 Sustainability

DPN/A
EPS Next 2Y1.2%
EPS Next 3Y4.97%
ALVAP.PA Yearly Income VS Free CF VS DividendALVAP.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 0 2M -2M 4M

More info and screens

KUMULUS VAPE

EPA:ALVAP (5/20/2025, 7:00:00 PM)

5.34

+0.28 (+5.53%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners36.98%
Ins Owner ChangeN/A
Market Cap16.39M
Analysts86
Price Target8.82 (65.17%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.01%
Yearly Dividend0.1
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-2.81%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-8.47%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.1%
Valuation
Industry RankSector Rank
PE 5.56
Fwd PE 6.1
P/S 0.18
P/FCF N/A
P/OCF N/A
P/B 1.1
P/tB 1.47
EV/EBITDA 2.87
EPS(TTM)0.96
EY17.98%
EPS(NY)0.88
Fwd EY16.4%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS30.2
BVpS4.84
TBVpS3.63
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 11.93%
ROE 19.68%
ROCE 23.81%
ROIC 17.26%
ROICexc 24.45%
ROICexgc 33.91%
OM 4.84%
PM (TTM) 3.16%
GM 22.53%
FCFM N/A
ROA(3y)10.22%
ROA(5y)8.85%
ROE(3y)15.46%
ROE(5y)14.08%
ROIC(3y)14.54%
ROIC(5y)14.31%
ROICexc(3y)19.15%
ROICexc(5y)21.12%
ROICexgc(3y)22.01%
ROICexgc(5y)23.52%
ROCE(3y)20.08%
ROCE(5y)19.87%
ROICexcg growth 3Y-11.77%
ROICexcg growth 5YN/A
ROICexc growth 3Y-20.68%
ROICexc growth 5YN/A
OM growth 3Y-6.99%
OM growth 5YN/A
PM growth 3Y-6.57%
PM growth 5YN/A
GM growth 3Y3.52%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover3.78
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA 0.76
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.49
Quick Ratio 1.89
Altman-Z 6.44
F-ScoreN/A
WACC7.3%
ROIC/WACC2.36
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.14%
EPS 3Y28.22%
EPS 5YN/A
EPS Q2Q%-18.21%
EPS Next Y-2.41%
EPS Next 2Y1.2%
EPS Next 3Y4.97%
EPS Next 5YN/A
Revenue 1Y (TTM)53.66%
Revenue growth 3Y40.66%
Revenue growth 5YN/A
Sales Q2Q%2.01%
Revenue Next Year1.16%
Revenue Next 2Y1.36%
Revenue Next 3Y2.38%
Revenue Next 5YN/A
EBIT growth 1Y22.47%
EBIT growth 3Y30.83%
EBIT growth 5YN/A
EBIT Next Year6.77%
EBIT Next 3Y6.35%
EBIT Next 5YN/A
FCF growth 1Y299.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y413.64%
OCF growth 3YN/A
OCF growth 5YN/A